Data from MIMS Learning - Monthly Index of Medical Specialities - Curated by EPG Health - Last updated 25 April 2017

Accrediting Body

MIMS Learning - Monthly Index of Medical Specialities

Expected length

90 minutes

Award

1 credit

Subscription

Member benefit (0)

After reading this activity, healthcare professionals should be better able to:

  • Describe the classification of lung cancer
  • Identify suspected cases of lung cancer and know when to refer
  • Understand current management of lung cancer
  • Have an awareness of prognosis and disease outcomes

Category Value
Expiry date 08-Aug-18
Credit type Credit
Registration with provider required Yes
Certificate available Yes
Author(s) Dr David Breen and Dr Vincent Brennan
Multi session No
Intended audience(s) General Practitioner, Specialist
Funded by MIMS- Monthly Index of Medical Specialities

Start CME

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Sleep Apnea

Sleep Apnea

Sleep apnea is a chronic condition characterised by recurrent interruptions in breathing throughout the sleep cycle. Learn about the two main types of sleep apnea and hear from experts as they present the latest research at the Sleep and Breathing conference (Marseille, 2019).

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Biosimilars in Oncology Knowledge Centre

Biosimilars in Oncology Knowledge Centre

What are biologics and how do they differ from small molecule medicines? Discover more about their development, as well as the manufacturing and regulatory processes in the Biosimilars in Oncology Knowledge Centre.

Load more

Related Content